Комплексное лечение больных местнораспространенным раком головки поджелудочной железы

Литература:

1. Котельников А.Г. Выбор метода лечения больных раком головки поджелудочной железы и периампулярной зоны:

Дис. докт. мед. наук. М. 2001. 242 с.

2. Расулов Р.И. Реконструктивно#восстановительные вмешательства на магистральных сосудах при повреждениях и онкологических заболеваниях органов живота: Дис. докт.

мед. наук. Томск, 2006. 388 с.

3. Kalser M.H. Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Arch. Surg. 1985; 120 (8): 899–903.

4. Reber H.A. Gloor В. Radical pancreatectomy. Surg. Oncol. Clin.

North Am. 1998; 7 (1): 157–163.

5. Bold R.J. Charnsangavej С. Cleary K.R. Jennings M. Madray A.,

Leach S.D. Abbruzzese J.L. Pisters P.W. Lee J.E. Evans D.B.

Major vascular resections as part of pancreaticoduodenectomy

for cancer: radiologic, intraoperative, and pathologic analysis. J.

Gastrointest. Surg. 1999; 3 (3): 233–243.

6. Launois B. Stasik С. Bardaxoglou Е. Meunier B. Campion J.P.,

Greco L. Sutherland F. Who benefit from portal vein resection

during pancreaticoduodenectomy for pancreatic cancer? Wld J.

Surg.1999; 23 (9): 926–929.

7. Забежинский Д.А. Комбинированное лечение больных резектабельным раком поджелудочной железы: Дис. канд.

мед. наук. М. 2009. 144 с.

8. Matsuda M. Nimura Y. Perineural invasion of pancreas head

carcinoma. Nippon Geka Gakkai Zasshi.1983; 84(8): 719–728.

9. Nagai H. Kuroda А. Morioka Y. Lymphatic and local spread of

T1 and T2 pancreatic cancer. Ann. Surg. 1986; 204 (1): 65–71.

10. Kayahara M. Nagakawa Т. Ueno К. Ohta T. Takeda T.,

Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the of recurrence as determined by autopsy and

diagnostic imaging. Cancer. 1993; 72 (7): 2118–2123.

11. Nakao A. Harada Т. Nonami Т. Kaneko T. Takagi H. Clinical

significance of carcinoma invasion of the extrapancreatic nerve

plexus in pancreatic cancer. Pancreas. 1996; 12 (4): 357–361.

12. Hirai I. Kimura W. Ozawa К. Kudo S. Suto K. Kuzu H. Fuse A.

Perineural invasion in pancreatic cancer. Pancreas. 2002; 24 (1):

15–25.

13. Freeny P.C. Radiology of the pancreas: two decades of progress

in imaging and intervention. Am. J. Roentgenol. 1988; 150 (5):

975–981.

14. Warshaw A.L. Gu Z. Wittenberg J. Waltman A.C. Preoperative

staging and assessment of resectability of pancreatic cancer.

Arch. Surg. 1990; 125 (2): 230–233.

15. Diehl S.J. Lehman K.J. Sadick М. Lachmann R. Georgi M.

Pancreatic cancer: value of dual#phase helical CT in assessing

respectability. Radiology. 1998; 206 (2): 373–378.

16. Fronzo L.A. Cymerman J. Egrari S. O'Connell T.X. Unresectable pancreatic carcinoma: correlating length of survival with

choice of palliative bypass. Ann. Surg. 1999; 65 (10): 955–958.

17. Ishikawa O. Ohigashi Н. Sasaki Y. Kabuto T. Fukuda I.,

Furukawa H. Imaoka S. Iwanaga T. Practical usefulness of lymphatic and connective tissue clearence for the carcinoma of the

pancreatic head. Ann. Surg. 1988; 208 (2): 215–220.

18. Michelassi F. Erroi F. Dawson P.J. Pietrabissa A. Noda S.,

Handcock M. Block G.E. Experience with 647 consecutive

tumors of the duodenum, ampulla, head of the pancreas and distal common bile duct. Ann. Surg. 1989; 210 (4): 545–556.

19. Griffin J.F. Smalley S.R. Jewell W. Paradelo J.C. Reymond R.D.,

Hassanein R.E. Evans R.G. Patterns of failure after curative

resection of pancreatic carcinoma. Cancer. 1990; 66 (1): 56–61.

20. Westerdahl J. Andren8Sandberg А. Ihse I. Recurrence of

exocrine pancreatic cancer#local or hepatic? Hepatogastroenterology. 1993; 40 (4): 384–387.

21. Andren8Sandberg A. Pattern of recurrence after pancreaticoduodenectomy for exocrine pancreatic cancer: correlation with survival. Pancreatoduodenectomy. Tokyo: Springer, 1997; 417–423.

22. Moossa A.R. Scott M.H. Lavelle8Jones M. The place of total and

extended total pancreatectomy in pancreatic cancer. Wld J. Surg.

1984; 8 (6): 895–899.

23. Heerden J.A. Pancreatic resection for carcinoma of the pancreas:

Whipple versus total pancreatectomy – an institutional perspective. Wld J. Surg.1984; 8 (6): 880–888.

24. Fortner J.G. Regional resection of cancer of the pancreas: a new

surgical approach. Surgery. 1973; 73 (2): 307–320.

25. Howard J.M. Development and progress in resective surgery for

pancreatic cancer. Wld J. Surg. 1999; 23 (9): 901–906.

26. Егоров В.И. Вишневский В.А. Козлов И.А. Кригер А.Г. Шев8

ченко Т.В. Мелехина О.В. Результаты стандартной и расширенной панкреатодуоденальной резекции при протоковой

аденокарциноме поджелудочной железы. Анн. хир. гепатол. 2008; 13 (4): 19–32.

27. Sasson A.R. Hoffman J.P. Ross E.A. Kagan S.A. Pingpank J.F.,

Eisenberg B.L. En bloc resection for locally advanced cancer of

the pancreas: is it worthwhile? J. Gastrointest Surg. 2002; 6 (2):

147–157; discussion 157–158.

28. Hartwig W. Hackert T. Hinz U. Hassenpflug M. Strobel O.,

Büchler M.W. Werner J. Multivisceral resection for pancreatic

malignancies: risk#analysis and long#term outcome. Ann. Surg.

2009; 250 (1): 81–87.

29. Vladov N. Takorov I. Kazarov K. Mutafchiiski V. Vasilevski I.,

Sergeev S. Odiseeva E. Surgical potentialities for the treatment

of pancreatic cancer. Hepatogastroenterology. 2012; 59 (113):

280–283.

30. Jemal A. Siegel R. Ward E. Murray T. Xu J. Smigal C. Thun M.J.

Cancer statistics, 2006. CA Cancer J. Clin. 2006; 56 (2): 106–130.

31. Saif M.W. Pancreatic cancer: are we moving forward yet? Higlights from the Gastrointestinal Cancers Symposium. Orlando,

FL, USA. January 20th, 2007. J.O.P. 2007; 8 (2): 166–176.

32. Кубышкин В.А. Вишневский В.А. Рак поджелудочной железы. М. ИД Медпрактика#М, 2003. 386 с.

33. Блохин Н.Н. Итин А.Б. Клименков А.А. Рак поджелудочной

железы и внепеченочных желчных протоков. М. Медицина, 1982. 259 с.

34. Böttger T.C. Störkel S. Wellek S. Stöckle M. Junginger T.

Factors influencing survival after resection of pancreatic cancer.

A DNA analysis and a histomorphologic study. Cancer. 1994;

73 (1): 63–73.

35. Nagakawa T. Kobayashi H. Ueno K. Ohta T. Kayahara M.,

Mori K. Nakano T. Takeda T. Konishi I. Miyazaki I. The pattern

of lymph node involvement in carcinoma of the head of the pancreas. A histologic study of the surgical findings in patients undergoing extensive nodal dissections. Int. J. Pancreatol. 1993; 13 (1):

15–22.

36. Nagakawa T. Kobayashi H. Ueno K. Ohta T. Kayahara M.,

Miyazaki I. Clinical study of lymphatic flow to the paraaortic

lymph nodes in carcinoma of the head of the pancreas. Cancer.

1994; 73 (4): 1155–1162.

37. Nakao A. Harada A. Nonami T. Kaneko T. Murakami H.,

Inoue S. Takeuchi Y. Takagi H. Lymph node metastases in carcinoma of the head of the pancreas region. Br. J. Surg. 1995; 82

(3): 399–402.

38. Kayahara M. Nagakawa T. Kobayashi H. Mori K. Nakano T.,

Kadoya N. Ohta T. Ueno K. Miyazaki I. Lymphatic flow in carcinoma of the head of the pancreas. Cancer. 1992; 70 (8):

2061–2066.

39. Мелехова О.В. Прогнозирование течения рака поджелудочной железы в зависимости от местного распространения и

регионарного метастазирования: Дис. канд. мед. наук.

М. 2009. 160 с.

40. Fujii Y. Shimada H. Endo I. Yoshida K. Matsuo K. Takeda K.,

Ueda M. Morioka D. Tanaka K. Togo S. Management of massive arterial hemorrhage after pancreatobiliary surgery: does

embolotherapy contribute to successful outcome? J. Gastrointest

Surg. 2007; 11 (4): 432–438.

41. Martin R.C. Scoggins C.R. Egnatashvili V. Staley C.A.,

McMasters K.M. Kooby D.A. Arterial and venous resection for

pancreatic adenocarcinoma: operative and long#term outcomes.

Arch. Surg. 2009; 144 (2): 154–159.

42. Yeo C.J. Sohn T.A. Cameron J.L. Hruban R.H. Lillemoe K.D.,

Pitt H.A. Periampullary adenocarcinoma Analysis of 5#yers survivors. Ann. Surg. 1998; 227 (6): 821–831.

43. Bartoli F.G. Arnone G.B. Ravera G. Bachi V. Pancreatic fistula

and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta#analysis regarding

15 years of literature. Anticancer Res. 1991; 11 (5): 1831–1848.

44. Klempa I. Schwedes U. Usadel K.H. Prevention of postoperative

pancreatic complications following duodenopancreatectomy

using somatostatin. Chirurg. 1979; 50 (7): 427–431.

45. Lowy A.M. Lee J.E. Pisters P.W. Davidson B.S. Fenoglio C.J.,

Stanford P. Jinnah R. Evans D.B. Prospective, randomized trial

of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann. Surg. 1997; 226 (5):

632–641.

46. Yeo C.J. Cameron J.L. Lillemoe K.D. Sauter P.K. Coleman J.,

Sohn T.A. Campbell K.A. Choti M.A. Does prophylactic

octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo#controlled trial. Ann. Surg. 2000;

232 (3): 419–429.

47. Grace P.A. Pitt H.A. Tompkins R.K. DenBesten L. Long8

mire W.P. Jr. Decreased morbidity and mortality after pancreatoduodenectomy. Am. J. Surg. 1986; 151 (1): 141–149.

48. Funovics J.M. Zöch G. Wenzl E. Schulz F. Progress in reconstruction after resection of the head of the pancreas. Surg.

Gynecol. Obstet. 1987; 164 (6): 545–548.

49. Matsumoto Y. Fujii H. Miura K. Inoue S. Sekikawa T.,

Aoyama H. Ohnishi N. Sakai K. Suda K. Successful pancreatojejunal anastomosis for pancreatoduodenectomy. Surg. Gynecol.

Obstet. 1992; 175 (6): 555–562.

50. Carr J.A. Ajlouni M. Wollner I. Wong D. Velanovich V. Adenocarcinoma of the head of the pancreas: effects of surgical and

nonsurgical therapy on survival##a ten#year experience. Ann.

Surg. 1999; 65 (12): 1143–1149.

51. Krysa J. Miller M. Kukreja N. Steger A. Pancreatic cancer –

is an aggressive approach justified? Ann. R. Coll. Surg. Engl.

2005; 87 (3): 163–166.

52. Wenger F.A. Peter F. Zieren J. Steiert A. Jacobi C.A. Müller J.M.

Prognosis factors in carcinoma of the head of the pancreas. Dig.

Surg. 2000; 17 (1): 29–35.

53. Klinkenbijl J.H. Jeekel J. Sahmoud T. van Pel R. Couvreur M.L.,

Veenhof C.H. Arnaud J.P. Gonzalez D.G. de Wit L.T. Hennip8

man A. Wils J. Adjuvant adiotherapy and 5#fluorouracil after

curative resection of cancer of the pancreas and periampullary

region: phase III trial of the EORTC gastrointestinal tract cancer

cooperative group. Ann. Surg. 1999; 230 (6): 776–782; discussion 782–784.

54. Bakkevold K.E. Arnesjø B. Dahl O. Kambestad B. Adjuvant

combination chemotherapy (AMF) following radical resection

of carcinoma of the pancreas and papilla of Vater#results of

a controlled, prospective, randomised multicentre study. Eur.

J. Cancer. 1993; 29A (5): 698–703.

55. Neoptolemos J.P. Stocken D.D. Friess H. Bassi C. Dunn J.A.,

Hickey H. Beger H. Fernandez8Cruz L. Dervenis C. Lacaine F.,

Falconi M. Pederzoli P. Pap A. Spooner D. Kerr D.J.,

Büchler M.W. A randomized trial of chemoradiotherapy and

chemotherapy after resection of pancreatic cancer. N. Engl. J.

Med. 2004; 350 (12): 1200–1210. Erratum in: N. Engl. J. Med.

2004; 351 (7): 726.

56. Regine W.F. Winter K.A. Abrams R.A. Safran H. Hoffman J.P.,

Konski A. Benson A.B. Macdonald J.S. Kudrimoti M.R.,

Fromm M.L. Haddock M.G. Schaefer P. Willett C.G. Rich T.A.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil#based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. J.A.M.A.

2008; 299 (9): 1019–1026.

57. Ahlgren J.D. Chemotherapy for pancreatic carcinoma. Cancer.

1996; 78 (3 Suppl): 654–663.

58. Ducreux M. Boige V. Malka D. Emerging drugs in pancreatic

cancer. Expert Opin. Emerg. Drugs. 2004; 9 (1): 73–89.

59. Krzyzanowska M.K. Weeks J.C. Earle C.C. Treatment of locally

advanced pancreatic cancer in the real world: population-based

practices and effectiveness. J. Clin. Oncol. 2003; 21 (18):

3409–3414.

60. Lorenz M. Petrowsky H. Heinrich S. Janshon G. Staib8Sebler E.,

Poloczek Y. Gog C. Oremek G. Encke A. Isolated hypoxic pefusion with mitomycin C in patients with advanced pancreatic

cancer. Eur. J. Surg. Oncol. 1998; 24 (6): 542–547.

61. Cohen L. Hendrickson F.R. Lennox A.J. Kroc T.K. Hatcher M.A.,

Bennett B.R. Pancreatic cancer: treatment with neutron irradiation alone and with chemotherapy. Radiology. 1996; 200 (3):

627–630.

62. Imamura M. Doi R. Imaizumi T. Funakoshi A. Wakasugi H.,

Sunamura M. Ogata Y. Hishinuma S. Asano T. Aikou T.,

Hosotani R. Maetani S. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery. 2004; 136 (5): 1003–1011.

63. Smeenk H.G. Incrocci L. Kazemier G. van Dekken H. Tran K.T.,

Jeekel J. van Eijck C.H. Adjuvant 5#FU#based chemoradiotherapy for patients undergoing R#1/R#2 resections for pancreatic

cancer. Dig. Surg. 2005; 22 (5): 321–328.